Cancer Treatment Fund
for Paediatric Patients

The YouWeCan Cancer Treatment Fund for Paediatric Patients provides financial assistance for the treatment of eligible cancer patients, to a maximum limit of Rs. 3,00,000.00 (rupees three lakhs) per patient. Only patients belonging to underprivileged backgrounds, who are below 16 years of age, are eligible to receive support under the fund.

The entire cost of treatment of shortlisted patients is supported, as per the treatment plan of the hospital, including (but not limited to) diagnostic tests, investigations, chemotherapy, radiation therapy, surgery and cost of medication. All medical services related to the treatment are provided directly by the partner hospital. YouWeCan Foundation’s role is limited to providing financial aid to support the cost of treatment.

Strict processes are in place for due diligence and screening of cases. To ensure transparency and to maintain strong financial control, funds are disbursed directly to hospitals and not to beneficiaries or their caregivers/ family.

1

Download & print the application form

2

Fill the application & attach supporting documents

3

Submit the form via email or post
  • Medical grant under YouWeCan Cancer Treatment Fund for Paediatric Patients, is open for cancer patients only.

  • Patient should be an Indian citizen residing in India.

  • Patient should be below the age of 16 years.

  • Patients with an annual family income exceeding Rs. 200,000/- (rupees two lakh only) will not be considered eligible for medical grant under this fund.

  • Patients who are covered under the Pradhan Mantri Jan Arogya Yojana (PMJAY) will not be considered eligible for medical grant under this fund.

  • Patients with immediate family members who are government employees covered under the Central Government Health Scheme (CGHS), or are employees who are covered under the Employees State Insurance Scheme (ESIS), or are employees who are eligible for aid from their employers, will not be considered eligible for medical grant under this fund.